Home » News » Politics » Primary Plus
Shaheen vote on stimulus funding raises questions
In 2009, Bill Shaheen became an adviser to a Southern California startup, Ultrawave labs, which was developing new technology to screen for breast cancer. Around the same time his firm, Shaheen and Gordon, created a “Stimulus Opportunities Team.”
“Today’s report raises very serious ethical questions about Sen. Shaheen’s finances and a conflict of interest involving her husband’s lobbying firm,” said Horn, referring to an article in the Boston Globe. “She has long championed the wasteful stimulus boondoggle, and it’s troubling to learn that she financially benefited from a company that received stimulus funding.”
Mike Noonan, managing director and president of Shaheen and Gordon, said the Manchester law firm’s Stimulus Opportunities Team existed for a very brief time.
Harrell Kirstein, communications director at the Shaheen campaign office, said the senator’s support for breast cancer research had nothing to do with Ultrawave.
“It absolutely is a concern,” Charlton Copeland, former chair of the Miami-Dade Commission on Ethics and Public Trust and a professor at the University of Miami told the Boston Globe. “It raises questions because so much of the work of this kind of policy-making takes place outside of the specter of the public eye.”
Blackwater verdict stuns NH dad
Making it up: Shameless state Senate attacks
A good first impression
Thieves target cars in Hollis neighborhood